WeVote

Bill

Bill

SB 461

AN ACT RELATING TO INSURANCE -- PRESCRIPTION DRUG BENEFITS

2025 Regular Session Introduced by Jake Bissaillon and 9 co-sponsors

SB 461 establishes new insurance requirements for prescription drug coverage in Rhode Island, affecting patient access and medication costs under health plans.

06/03/2025 Senate read and passed
0
WeVote Research Nonpartisan
Bill Summary · SB 461

Legislative bill overview

SB 461 modifies Rhode Island's insurance regulations governing prescription drug benefits coverage. The bill establishes new requirements for how health insurance plans must handle pharmacy benefits, likely including provisions around formulary management, prior authorization processes, or cost-sharing for medications.

Why is this important

Prescription drug costs are a major driver of healthcare expenses and affordability concerns for Rhode Island residents. Changes to how insurance covers medications directly affect patient access to treatments and out-of-pocket costs, making this a significant consumer protection and public health issue.

Potential points of contention

  • Industry compliance costs: Insurance companies and pharmacy benefit managers may argue the bill increases administrative burden and ultimately raises premium costs for consumers
  • Formulary restrictions vs. access: Tension between insurers' cost-control measures (limiting which drugs are covered) and patient advocates' demands for broader medication access
  • Implementation timeline: The bill's requirements may be impractical for plans already operating under existing contracts, creating transition challenges and potential rate increases

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.